Current therapies for asthma: Promise and limitations

Chest

Volumn 111, Issue 2 SUPPL., 1997, Pages 17S-26S

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

anticholinergic agent; asthma; efficacy; eromone; glucocorticoid; inhalation therapy; leukotriene; theophylline; 2 agonist

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CROMOGLYCATE DISODIUM; FORMOTEROL; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5; INTERLEUKIN 8; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; NEDOCROMIL SODIUM; OXITROPIUM BROMIDE; RANTES; SALMETEROL; TERBUTALINE; THEOPHYLLINE;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG MIXTURE; DRUG TARGETING; DRUG TOLERANCE; HUMAN; IMMUNOMODULATION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RESPIRATORY TRACT INFLAMMATION; RISK BENEFIT ANALYSIS; SIDE EFFECT;

EID: 0031039796     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Barnes PJ. New drugs for asthma. Eur Respir J 1992; 5:1126-36
2. Vermeire PA, Wittesaele WM, Janssens E, et al. European audit of asthma therapy. Chest 1986; 90(suppl 5):58-61
3. Lask B. International consensus report on diagnosis and management of asthma [letter]. Clin Exp Allergy 1992; 22(suppl 1):1-72
4. Carstairs JR, Nimino AJ, Barnes PJ. Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis 1985; 132:541-47
5. 2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: correlation with receptor autoradiography. Eur J Pharmacol 1991; 206:133-38
6. Butchers PR, Skidmore IF, Vardey CJ, et al. Characterisation of the receptor mediating antianaphylactic effects of beta-adrenoceptor agonists in human lung tissues in vitro. Br J Pharmacol 1980; 71:663-67
7. Barnes PJ, Adcock IM. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993; 14:436-41
8. Kwon OJ, An BT, Collins PD, et al. Tumor necrosis factor-induced interleukin 8 expression in cultured human epithelial cells. Am J Physiol 1994; 11:L398-405
9. Kwon OJ, Jose PJ, Robbins RA, et al. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol 1995; 12:488-96
10. Sousa AR, Poston RN, Lane SJ, et al. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am Rev Respir Dis 1993; 147:1557-61
11. Mitchell JA, Belvisi MG, Akarasereenont P, et al. Induction of cyclooxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol 1994; 113:1008-14
12. Robbins RA, Barnes PJ, Springall DR, et al. Expression of inducible nitric oxide synthase in human bronchial epithelial cells. Biochem Biophys Res Commun 1994; 203:209-18
13. Schleimer RP. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic application in asthma. Am Rev Respir Dis 1990; 141:(2 pt 2)S59-69
14. Pauwels R, van Renterghem D, van der Straeten M, et al. The effect of theophylline and enprophylline on allergen-induced bronchoconstriction. J Allergy Clin Immunol 1985; 76:583-90
15. Ward AJ, McKenniff M, Evans JM, et al. Theophylline: an immunomodulatory role in asthma? Am Rev Respir Dis 1993; 147:518-23
16. Sullivan P, Bekir S, Jaffar Z, et al. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994; 343:1006-08
17. Manolitsas ND, Wang J, Devalia JL, et al. Regular albuterol, nedocromil sodium and bronchial inflammation in asthma. Am J Respir Grit Care Med 1995; 152:1925-30
18. Heinke S, Szues G, Norris A, et al. Inhibition of volume-activated chloride currents in endothelial cells by cromones. Br J Pharmacol 1995; 115:1392-98
19. Barnes PJ, Holgate ST, Laitinen LA, et al. Asthma mechanisms, determinants of severity and treatment: the role of nedocromil sodium. Clin Exp Allergy 1995; 25:771-87
20. Svendsen UG, Jorgensen H. Inhaled nedocromil sodium as additional treatment to high dose inhaled corticosteroids in the management of bronchial asthma. Eur Respir J 1991; 4:992-99
21. Tamaoki J, Chiyotani A, Tagaya E, et al. Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis. Thorax 1994; 49:545-48
22. Gross NJ. Ipratropium bromide. N Engl J Med 1988; 319: 486-94
23. O'Driscoll BR, Taylor RJ, Horsley MG, et al. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet 1989; 1:1418-20
24. Barnes PJ. Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 1995; 152:838-60
25. 2-agonists. Am J Respir Crit Care Med 1994; 150:381-87
26. 2-adrenoceptors. J Appl Physiol 1988; 65:700-05
27. Devalia JL, Sapsford RJ, Rusznak C, et al. The effects of salmeterol and salbutamol on ciliary beat frequency of cultured human bronchial epithelial cells in vitro. Pulm Pharmacol 1992; 5:257-63